Publicaciones en las que colabora con JOSE BELLVER PRADAS (21)

2021

  1. Obesity Affects Endometrial Receptivity by Displacing the Window of Implantation

    Reproductive Sciences, Vol. 28, Núm. 11, pp. 3171-3180

2018

  1. GnRH antagonist for endometrial priming in an oocyte donation programme: a prospective, randomized controlled trial

    Reproductive BioMedicine Online, Vol. 37, Núm. 4, pp. 415-424

  2. Implantation failure of endometrial origin: What is new?

    Current Opinion in Obstetrics and Gynecology, Vol. 30, Núm. 4, pp. 229-236

2017

  1. Does an increased body mass index affect endometrial gene expression patterns in infertile patients? A functional genomics analysis

    Fertility and Sterility, Vol. 107, Núm. 3, pp. 740-748.e2

  2. In vitro fertilization with preimplantation genetic diagnosis for aneuploidies in advanced maternal age: a randomized, controlled study

    Fertility and Sterility, Vol. 107, Núm. 5, pp. 1122-1129

2015

  1. Art and uterine pathology: How relevant is the maternal side for implantation?

    Human Reproduction Update, Vol. 21, Núm. 1, pp. 13-38

2014

  1. Deciphering the proteomic signature of human endometrial receptivity

    Human Reproduction, Vol. 29, Núm. 9, pp. 1957-1967

  2. Reply: Endometrial scratching for women with repeated implantation failure

    Human Reproduction

  3. Scratching beneath 'the Scratching Case': Systematic reviews and metaanalyses, the back door for evidencebased medicine

    Human Reproduction, Vol. 29, Núm. 8, pp. 1618-1621

2013

  1. Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: Two randomized trials

    Fertility and Sterility, Vol. 99, Núm. 5, pp. 1400-1407

2011

  1. Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization (IVF) cycles: A new approach to measuring the likelihood of IVF success

    Fertility and Sterility, Vol. 96, Núm. 1, pp. 40-46

  2. Cumulative live-birth rates per total number of embryos needed to reach newborn in consecutive in vitro fertilization cycles: A new approach to measuring the likelihood of in vitro fertilization success

    Obstetrical and Gynecological Survey

2007

  1. Implantation is apparently unaffected by the dopamine agonist Cabergoline when administered to prevent ovarian hyperstimulation syndrome in women undergoing assisted reproduction treatment: A pilot study

    Human Reproduction, Vol. 22, Núm. 12, pp. 3210-3214

2006

  1. Interactions of the hormones leptin, ghrelin, adiponectin, resistin, and PYY3-36 with the reproductive system

    Fertility and Sterility, Vol. 85, Núm. 6, pp. 1563-1581

  2. Obesity and assisted reproductive technology outcomes

    Reproductive BioMedicine Online, Vol. 12, Núm. 5, pp. 562-568

2005

  1. Similar endometrial development in oocyte donors treated with either high- or standard-dose GnRH antagonist compared to treatment with a GnRH agonist or in natural cycles

    Human Reproduction, Vol. 20, Núm. 12, pp. 3318-3327

2004

  1. Intravenous albumin did not prevent ovarian hyperstimulation syndrome in in vitro fertilization cycles

    Evidence-based Obstetrics and Gynecology, Vol. 6, Núm. 4, pp. 194-195

  2. Report of the results of a 2 year programme of sperm wash and ICSI treatment for human immunodeficiency virus and hepatitis C virus serodiscordant couples

    Human Reproduction, Vol. 19, Núm. 11, pp. 2581-2586

2003

  1. Intravenous albumin does not prevent moderate-severe ovarian hyperstimulation syndrome in high-risk IVF patients: A randomized controlled study

    Human Reproduction, Vol. 18, Núm. 11, pp. 2283-2288

  2. Obesity and the risk of spontaneous abortion after oocyte donation

    Fertility and Sterility, Vol. 79, Núm. 5, pp. 1136-1140